Peptide library › Bone health
Abaloparatide
Also known as Tymlos, Eladynos
Daily bone-building injection for osteoporosis in people at high risk of fractures.
What people use it for
- Osteoporosis with high fracture risk (women after menopause and men)
What Abaloparatide does in the body
Mimics PTHrP, a relative of parathyroid hormone. Given in short daily pulses, it stimulates bone-building cells more than bone-removing cells, so bone density rises.
Strength of evidence
Strong: the ACTIVE trial cut new spine fractures by about 86% versus placebo.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Dizziness and fast heart rate, especially after the first doses
- Raised calcium in blood or urine
- Nausea
- Injection-site reactions
Who should avoid it or take extra care
- Paget's disease of bone or unexplained high alkaline phosphatase
- Previous radiation therapy to the skeleton
- Bone cancer or cancer spread to bone
- Children and young adults with open growth plates
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2017 for women and in 2022 for men. Prescription only.
How it's taken
Route: Injection under the skin, once daily
How long it lasts (half-life): About 1.7 hours
Storage
Refrigerated before first use; then at room temperature for up to 30 days.
Latest research & news
- Real-world treatment patterns in patients receiving osteoanabolic osteoporosis therapy: a retrospective cross-sectional study
Research · Study · PubMed · Osteoporos Int · 19 Nov 2026 - Bilateral insufficiency fractures of the femoral condyles after discontinuation of glucocorticoid therapy for ulcerative colitis: A case report
Research · Study · PubMed · Mod Rheumatol Case Rep · 19 Nov 2026 - Changes in dystrophic calcification of the breast associated with abaloparatide therapy
Research · Case report · PubMed · JCEM Case Rep · 17 Nov 2026 - Osteoporosis Treatment in Lumbar Fusion: A Scoping Review
Research · Study · PubMed · Curr Osteoporos Rep · 16 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Abaloparatide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Abaloparatide in Fiala How to installMore in Bone health
- TeriparatideBone-building form of parathyroid hormone approved for severe osteoporosis.
- Calcitonin (salmon)Hormone from salmon used for Paget's disease of bone, high calcium and, less often now, osteoporosis.
- PalopegteriparatideDaily long-acting parathyroid hormone replacement for adults with hypoparathyroidism.
- Parathyroid hormoneFull-length lab-made parathyroid hormone for low calcium caused by hypoparathyroidism; supply has been limited.
- VosoritideDaily injection that helps children with achondroplasia, the most common form of dwarfism, grow faster.
- EtelcalcetideInjection given at dialysis to lower overactive parathyroid hormone in people with kidney failure.